Powered by: Motilal Oswal
2026-11-16 10:15:51 am | Source: Axis Securities Ltd
Buy Dabur India Ltd for Target Rs.460 by Axis Direct
Buy Dabur India  Ltd for Target Rs.460 by Axis Direct

Short-term Headwinds; Long-term Growth Intact

Est. Vs. Actual for Q2FY27: Revenue – BEAT; EBITDA – MISS; PAT – MISS

Changes in Estimates post Q2FY27

FY27E/FY28E: Revenue: 0%/0%; EBITDA: -1%/-2%; PAT: -2%/-4%

Recommendation Rationale

* Broad-based Revenue Growth: Dabur India delivered 11.6% YoY consolidated revenue growth in Q2FY27, driven by healthy domestic FMCG performance (10.5% revenue growth; 5.5% volume growth) and a 20% recovery in international business despite geopolitical headwinds. Domestic growth was led by Food & Beverages (+17%), with beverages recording mid-teens growth and foods maintaining resilience. Alternate channels continued to grow at a strong double-digit pace, while General Trade posted mid-to-high single-digit growth, aided by Project Saksham.

* Inflation-led Margin Pressure: Dabur’s EBITDA margin declined 68bps YoY to 17.7%, primarily due to elevated input costs, which led to a 59bps contraction in gross margin. Additionally, other operating expenses increased 23.6% YoY, further weighing on profitability.

* Outlook: Management reiterated its double-digit revenue growth guidance, supported by distribution expansion, premiumisation, operational efficiencies and targeted marketing investments in high-potential brands. The company aims to drive 1.5x cost savings through operational efficiencies and increase the premium portfolio’s contribution to 23% by FY30 from the current 20%.

Sector Outlook: Positive

Company Outlook & Guidance: Dabur’s long-term growth outlook remains intact, and we maintain our BUY rating on the stock. However, given the uncertainty surrounding the West Asia conflict, we have revised down our FY27/FY28 margin estimates.

Current Valuation: 38x Sep’28E EPS (Earlier Valuation: 42x Jun’28E EPS)

Current TP: Rs 460/share (Earlier TP: Rs 515/share).

Recommendation: With an upside potential of 19% from the CMP, we maintain our BUY rating on the stock

Financial Performance:

The company’s consolidated revenue grew by 11.6% YoY to Rs 3,563 Cr, with the India business growing by 10.7% YoY, while the international business expanded by 20% YoY in INR terms. EBITDA margins contracted by 68 bps YoY to 17.7%, led by a gross margin contraction of 59 bps. The company reported a PAT of Rs 506 Cr, up by 11.7% YoY.

Outlook & Recommendation

Dabur’s long-term growth strategy is anchored on strengthening core brands through targeted digital investments, accelerating premiumisation through innovative, high-margin offerings and expanding its presence in the health and wellness segment. The company is also focusing on portfolio rationalisation by pruning underperforming SKUs and redeploying resources towards high-growth categories. Further, Project Saksham (GTM 2.0) aims to improve general trade efficiency through distributor consolidation and better working capital management, while Dabur Ventures provides an avenue for strategic investments in emerging D2C brands. Operational and supply-chain efficiencies under Project Samriddhi are expected to drive cost savings and support reinvestment in growth initiatives. These strategic initiatives reinforce our confidence in Dabur’s long-term growth prospects. We maintain our BUY rating with a TP of Rs 460/share, valuing the stock at 38x Sep’28E EPS, implying an upside potential of 19% from the CMP.

Key Risks to Our Estimates and TP

* War-led inflation, demand slowdown, and advertisement spends.

 

For More Axis Securities Disclaimer https://simplehai.axisdirect.in/disclaimer-home

SEBI Registration number is INZ000161633

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here